Growing Terumo has been busy building up its current facilities in Japan. After expanding the production lines at its site in Yamaguchi in 2023, the company is now working on adding new production ...

Morningstar brands and products Company Portfolio ...

WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health ...

After delivering strong sales growth last year and with more expansion in mind, CDMO giant Wuxi Biologics is breaking ground on a new microbial production plant in Chengdu, China.. The 95,000 ...

“NAMSA and WuXi AppTec’s Medical Device Testing Operations have different areas of expertise but serve the same client base and will enhance the client experience by combining capabilities.

WuXi Biologics completed the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000 L single-use bioreactors (SUBs) in the second drug substance line ...